Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 10
2005 10
2006 17
2007 20
2008 16
2009 11
2010 22
2011 22
2012 37
2013 34
2014 30
2015 29
2016 49
2017 48
2018 46
2019 74
2020 61
2021 81
2022 73
2023 84
2024 37

Text availability

Article attribute

Article type

Publication date

Search Results

725 results

Results by year

Filters applied: . Clear all
Page 1
Food additives: From functions to analytical methods.
Wu L, Zhang C, Long Y, Chen Q, Zhang W, Liu G. Wu L, et al. Among authors: zhang w. Crit Rev Food Sci Nutr. 2022;62(30):8497-8517. doi: 10.1080/10408398.2021.1929823. Epub 2021 Jun 1. Crit Rev Food Sci Nutr. 2022. PMID: 34058921 Review.
Acupuncture for cancer pain: an evidence-based clinical practice guideline.
Ge L, Wang Q, He Y, Wu D, Zhou Q, Xu N, Yang K, Chen Y, Zhang AL, Hua H, Huang J, Hui KK, Liang F, Wang L, Xu B, Yang Y, Zhang W, Zhao B, Zhu B, Guo X, Xue CC, Zhang H; International Trustworthy traditional Chinese Medicine Recommendations (TCM Recs) Working Group. Ge L, et al. Among authors: zhang w. Chin Med. 2022 Jan 5;17(1):8. doi: 10.1186/s13020-021-00558-4. Chin Med. 2022. PMID: 34983587 Free PMC article. Review.
Synthetic Genomes.
Zhang W, Mitchell LA, Bader JS, Boeke JD. Zhang W, et al. Annu Rev Biochem. 2020 Jun 20;89:77-101. doi: 10.1146/annurev-biochem-013118-110704. Annu Rev Biochem. 2020. PMID: 32569517 Review.
On the genetic basis of tail-loss evolution in humans and apes.
Xia B, Zhang W, Zhao G, Zhang X, Bai J, Brosh R, Wudzinska A, Huang E, Ashe H, Ellis G, Pour M, Zhao Y, Coelho C, Zhu Y, Miller A, Dasen JS, Maurano MT, Kim SY, Boeke JD, Yanai I. Xia B, et al. Among authors: zhang w. Nature. 2024 Feb;626(8001):1042-1048. doi: 10.1038/s41586-024-07095-8. Epub 2024 Feb 28. Nature. 2024. PMID: 38418917 Free PMC article.
Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial.
Yang Y, Qu S, Li J, Hu C, Xu M, Li W, Zhou T, Shen L, Wu H, Lang J, Hu G, Luo Z, Fu Z, Qu S, Feng W, Chen X, Lin S, Zhang W, Li X, Sun Y, Lin Z, Lin Q, Lei F, Long J, Hong J, Huang X, Zeng L, Wang P, He X, Zhang B, Yang Q, Zhang X, Zou J, Fang W, Zhang L. Yang Y, et al. Among authors: zhang w. Lancet Oncol. 2021 Aug;22(8):1162-1174. doi: 10.1016/S1470-2045(21)00302-8. Epub 2021 Jun 23. Lancet Oncol. 2021. PMID: 34174189 Clinical Trial.
725 results